Longevity & AgingResearch PaperOpen Access

How Aging Breaks the Muscle Neighborhood That Keeps Your Fibers Strong

A landmark review reveals how aging corrupts the cellular community surrounding muscle fibers, driving sarcopenia through disrupted molecular crosstalk.

Saturday, October 3, 2026 4 views
Published in J Adv Res
Cross-section of aged skeletal muscle tissue showing muscle fibers surrounded by fat infiltration, nerve terminals, and glowing cellular signals between cells

Summary

This comprehensive review from Central South University examines how aging dismantles the skeletal muscle microenvironment (SMME) — the niche of satellite cells, fibro/adipogenic progenitors, neurons, immune cells, and vasculature surrounding each muscle fiber. As these components deteriorate with age, their supportive molecular signals to myofibers are lost or turned harmful. Key disruptions include satellite cell senescence, FAP-driven fibrosis and fat infiltration, neuromuscular junction degeneration, macrophage polarization shifts, and vascular rarefaction. Together, these changes reduce muscle fiber maintenance, repair, and growth — culminating in sarcopenia. The authors also highlight how single-cell and spatial omics are beginning to map these interactions with unprecedented precision, opening new therapeutic avenues.

Detailed Summary

Sarcopenia — age-related loss of muscle mass and strength — affects 10–27% of older adults worldwide and costs over $2,000 per hospitalized patient annually. Despite its burden, effective therapies remain elusive, largely because the field has focused on muscle fibers in isolation rather than the complex cellular ecosystem surrounding them. This review from Xiangya Hospital, Central South University, synthesizes emerging evidence that sarcopenia is fundamentally a disease of disrupted microenvironmental crosstalk.

The skeletal muscle microenvironment (SMME) includes satellite cells (SCs), fibro/adipogenic progenitors (FAPs), macrophages, neurons, Schwann cells, endothelial cells, pericytes, and fibroblasts — all arranged in precise spatial layers around each myofiber. Under healthy conditions, these cells exchange trophic signals that sustain fiber mass, repair damage, and regulate metabolism. The review systematically documents how each component deteriorates with aging and how these changes impair the molecular dialogue with myofibers.

Satellite cells decline in number and function with age, accumulating senescence markers and secreting harmful factors like S100B, which activates RAGE receptors on myofibers to trigger atrophy. Senescent myofibers reciprocate by releasing ANGPTL2, suppressing SC self-renewal — a vicious bidirectional cycle. FAPs shift from secreting pro-myogenic factors (GDF10, IGF-1, WISP1, Follistatin, Periostin) toward fibrogenic and adipogenic programs, producing intramuscular fat and fibrosis. Aging macrophages fail to transition from pro-inflammatory M1 to regenerative M2 phenotypes, prolonging inflammation and impairing repair. Neuromuscular junctions degenerate as motor neurons retract and Schwann cells lose their supportive capacity. Capillary density falls, reducing oxygen and nutrient delivery, while pericyte dysfunction further compromises angiogenic responses.

The review also highlights feedback from myofibers to the SMME: senescent fibers reduce secretion of SPARC and IL-15, which normally suppress FAP adipogenesis; they also produce fewer pro-angiogenic signals, worsening vascular rarefaction. This bidirectional deterioration creates self-amplifying loops that accelerate sarcopenia progression beyond what any single-cell failure could explain.

Critically, the authors note that single-cell RNA sequencing and spatial transcriptomics are now enabling researchers to map these intercellular interactions in situ, revealing FAP subpopulations, macrophage heterogeneity, and myonuclear domain-specific senescence with unprecedented resolution. These tools promise to identify precise molecular targets — such as restoring GDF10 secretion from FAPs, blocking ANGPTL2 from senescent fibers, or rescuing NMJ integrity via Schwann cell support — that could translate into therapies for sarcopenia.

Key Findings

  • Senescent satellite cells secrete S100B activating myofiber RAGE receptors, while atrophic fibers release ANGPTL2 suppressing SC regeneration in a vicious cycle.
  • Aging FAPs reduce secretion of GDF10, IGF-1, WISP1, and Follistatin, shifting toward fibrosis and intramuscular fat that displaces contractile tissue.
  • Age-related macrophage polarization failure prolongs M1 inflammation and impairs the M2-driven repair phase needed for myofiber regeneration.
  • Neuromuscular junction degeneration — driven by motor neuron retraction and Schwann cell loss — precedes and accelerates myofiber atrophy in sarcopenia.
  • Capillary rarefaction and pericyte dysfunction reduce nutrient delivery, compounding fiber loss from impaired angiogenic signaling in aged muscle.

Methodology

This is a comprehensive narrative review synthesizing published experimental and clinical studies on age-related changes in the skeletal muscle microenvironment. The authors integrate findings from mouse genetic models (e.g., inducible Pax7 knockout), heterochronic parabiosis experiments, single-cell RNA sequencing datasets, and spatial transcriptomics studies. No original experimental data were generated.

Study Limitations

As a narrative review, it lacks a systematic literature search protocol, introducing potential selection bias in the studies cited. Many mechanistic findings are derived from mouse models and may not translate directly to human sarcopenia. The authors acknowledge significant knowledge gaps, particularly around quiescent SC paracrine effects and FAP subpopulation-specific contributions, which limit direct clinical translation at this time.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: